1000 Genentech, Inc.
This role involves applying computational approaches and machine learning models to accelerate antibody discovery and support portfolio projects within Roche's AI for Drug Discovery group. The position focuses on translating developability predictions and biophysical modeling into actionable guidance for antibody engineering teams across gRED and pRED. It requires collaboration with diverse scientific stakeholders to address real-world discovery challenges and advance innovative medicines for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 1000 Genentech, Inc..
Scientist, AI/ML — Antibody Developability
Ginkgo Bioworks
Scientist, Antibody Developability
Adaptyv Bio
Advisor - Antibody Developability Validation & Benchmarking
Eli Lilly and Company
Associate Director, Antibody Discovery & Characterization
Ginkgo Bioworks Inc.
Scientist Computational Structural Biology
argenx
Scientist Antibody Discovery
Global Channel Management